GE HealthCare (Nasdaq: GEHC) shares took a hit today on despite strong second-quarter results and an increased full-year ...

Cardiosense announced today that it received FDA 510 (k) clearance for its CardioTag wearable sensor device.

Versa Vascular recently closed an oversubscribed $27.3 million funding round, investor Santa Cruz Ventures announced.

Boston Scientific warned of the potential for rising low-voltage shock impedance (LVSI) associated with Reliance ...

Vexev announced today that it completed enrollment in a clinical trial evaluating its semi-autonomous ultrasound scanning technology.

Bioventus (Nasdaq:BVS) announced today that it received FDA 510(k) clearance for both its TalisMann and StimTrial offerings.